Aimmune Therapeutics, Inc. — Form D
Aimmune Therapeutics, Inc. of BRISBANE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-16. The offering totals $156.7M, of which $156.7M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-03-16
- Form: D
- Accession: 0001648920-18-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $156.7M
- Amount sold: $156.7M
- Minimum investment: $1
- Investors: 2
- Date of first sale: 2016-11-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-307907
Issuer
- Name: Aimmune Therapeutics, Inc.
- CIK: 0001631650
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 8000 MARINA BOULEVARD, BRISBANE, CA, 94005-1884
- Phone: (650) 614-5220
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Stephen G Dilly, Jr. | Director | Brisbane, CA |
| Stephen G Dilly, Jr. | Executive Officer | Brisbane, CA |
| Jeffrey H Knapp | Executive Officer | Brisbane, CA |
| Patrick G Enright | Director | San Diego, CA |
| Kathryn E Falberg | Director | New York, NY |
| Mark T Iwicki | Director | 3584 CM Utrecht, P7 |
| Mark D McDade | Director | Menlo Park, CA |
| Eric H Bjerkholt | Executive Officer | Brisbane, CA |
| Brett K Haumann | Director | Brisbane, CA |
| Daniel C Adelman | Executive Officer | Brisbane, CA |
| Mary M Rozenman | Executive Officer | Brisbane, CA |
| Susan E Barrowcliffe | Executive Officer | Brisbane, CA |
| Douglas T Sheehy | Executive Officer | Brisbane, CA |
| Stacey D Seltzer | Director | Brisbane, CA |
| Gregory E Behar | Director | Brisbane, CA |
| Jayson DA Dallas | Director | Brisbane, CA |
| Jayson DA Dallas | Executive Officer | Brisbane, CA |
| Joonkyoo (Anthony) L Yun | Director | San Mateo, CA |
| James D Tananbaum | Director | San Francisco, CA |
| Victor G Colunga | Executive Officer | San Mateo, CA |
| Bryan L Walser | Director | San Mateo, CA |
Other filings by this issuer (2)
More